Atom Investors’s Danimer Scientific, Inc. DNMR Stock Holding History

Atom Investors’s Portfolio DNMR Stock Details DNMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-290	Closed	-$34K	–	344
2022 Q3	$34K	Buy	+290	New	+$51.7K	0.01%	263
2021 Q4	–	Sell	-380	Closed	-$248K	–	434
2021 Q3	$248K	Buy	+380	New	+$279K	0.02%	265
2021 Q1	–	Sell	-2,750	Closed	-$2.59M	–	448
2020 Q4	$2.59M	Buy	+2,750	New	+$1.48M	0.26%	106

Other funds holding DNMR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Teramo Advisors Naples, Florida $529M AUM 20.59% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Atom Investors's DNMR Position: Q4 2022 in Review

Atom Investors sold out of Danimer Scientific, Inc. (DNMR) in Q4 2022, closing a stake of 290 shares — an estimated $34K sold.

Atom Investors first reported a position in DNMR in Q4 2020 and held it in 3 quarters. The position peaked at $2.59M in Q4 2020. 176 funds tracked by Wall St. Rank hold DNMR as of Q4 2022.

Atom Investors reported no remaining Danimer Scientific, Inc. position as of Q4 2022 after selling out during the quarter.
Atom Investors sold 290 Danimer Scientific, Inc. shares in Q4 2022, an estimated $34K.
Atom Investors first reported a position in Danimer Scientific, Inc. in Q4 2020 and held it in 3 quarters.
Atom Investors's Danimer Scientific, Inc. position peaked at $2.59M in Q4 2020.
176 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2022.

Based on Atom Investors's 13F filing for Q4 2022, filed 14 Feb 2023.